Pantherna Therapeutics Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
Pantherna Therapeutics General Information
Description
Operator of a biopharmaceutical company intended to develop therapeutics for vascular diseases. The company offers a technology based on nanoparticles for the delivery and expression of therapeutic messenger ribonucleic acid drugs in the endothelium, enabling physicians to restore endothelial cell function.
Contact Information
Website
www.pantherna-therapeutics.com(Operating Subsidiary)
Corporate Office
- Neuendorfstrasse 20b
- 16761 Hennigsdorf
- Germany
Corporate Office
- Neuendorfstrasse 20b
- 16761 Hennigsdorf
- Germany
Pantherna Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 01-Jun-2026 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC | 11-Jan-2022 | Completed | Clinical Trials - General | |||
| 3. Grant | 28-May-2021 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC | 02-Apr-2020 | $3.32M | $7.27M | Completed | Clinical Trials - General | |
| 1. Seed Round | 03-Jul-2019 | $3.96M | $3.96M | Completed | Clinical Trials - General |
Pantherna Therapeutics Comparisons
Industry
Financing
Details
Pantherna Therapeutics Competitors (75)
One of Pantherna Therapeutics’s 75 competitors is Brainstorm Cell Therapeutics, a Corporation company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Brainstorm Cell Therapeutics | Corporation | New York, NY | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA | ||||
| Elastrin | Venture Capital-Backed | Greenville, SC | ||||
| Modag | Venture Capital-Backed | Wendelsheim, Germany | ||||
| Alzheon | Venture Capital-Backed | Framingham, MA |
Pantherna Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Pantherna Therapeutics Patents
Pantherna Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4681739-A1 | Lipid nanoparticles for direct delivery | Pending | 19-Jul-2024 | ||
| WO-2026017865-A1 | Lipid nanoparticles for direct delivery | Pending | 19-Jul-2024 | ||
| AU-2023217931-A1 | Preparation for use in a method for the treatment and/or prevention of a disease | Pending | 14-Feb-2022 | ||
| EP-4226949-A1 | Preparation for use in a method for the treatment and/or prevention of a disease | Inactive | 14-Feb-2022 | ||
| EP-4479096-A1 | Preparation for use in a method for the treatment and/or prevention of a disease | Pending | 14-Feb-2022 | A61K9/1272 |
Pantherna Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pantherna Therapeutics Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bundesministerium für Wirtschaft und Klimaschutz | Government | Minority | ||
| Angel (individual) | Minority | |||
| European Investment Fund | Fund of Funds | Minority | ||
| European Union | Government | |||
| High-Tech Gründerfonds | Venture Capital | Minority |
Pantherna Therapeutics FAQs
-
When was Pantherna Therapeutics founded?
Pantherna Therapeutics was founded in 2017.
-
Where is Pantherna Therapeutics headquartered?
Pantherna Therapeutics is headquartered in Hennigsdorf, Germany.
-
What is the size of Pantherna Therapeutics?
Pantherna Therapeutics has 11 total employees.
-
What industry is Pantherna Therapeutics in?
Pantherna Therapeutics’s primary industry is Biotechnology.
-
Is Pantherna Therapeutics a private or public company?
Pantherna Therapeutics is a Private company.
-
What is Pantherna Therapeutics’s current revenue?
The current revenue for Pantherna Therapeutics is .
-
How much funding has Pantherna Therapeutics raised over time?
Pantherna Therapeutics has raised $11.8M.
-
Who are Pantherna Therapeutics’s investors?
Bundesministerium für Wirtschaft und Klimaschutz, , European Investment Fund, European Union, and High-Tech Gründerfonds are 5 of 7 investors who have invested in Pantherna Therapeutics.
-
Who are Pantherna Therapeutics’s competitors?
Brainstorm Cell Therapeutics, Genetix Biotherapeutics, Elastrin, Modag, and Alzheon are some of the 75 competitors of Pantherna Therapeutics.
-
When was Pantherna Therapeutics acquired?
Pantherna Therapeutics was acquired on 01-Jun-2026.
-
Who acquired Pantherna Therapeutics?
Pantherna Therapeutics was acquired by T-Curx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
